Richard Close
Stock Analyst at Canaccord Genuity
(2.04)
# 2,815
Out of 4,784 analysts
139
Total ratings
37.04%
Success rate
-7.74%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $34 → $35 | $26.00 | +34.62% | 9 | Mar 13, 2025 | |
| CLOV Clover Health Investments | Maintains: Buy | $4.2 → $4.5 | $3.59 | +25.35% | 3 | Mar 3, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $29 → $30 | $22.59 | +32.80% | 8 | Feb 28, 2025 | |
| PGNY Progyny | Maintains: Hold | $17 → $23 | $21.90 | +5.02% | 6 | Feb 28, 2025 | |
| HSTM HealthStream | Maintains: Hold | $29 → $30 | $32.03 | -6.34% | 6 | Feb 26, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $13 → $14 | $10.64 | +31.58% | 7 | Feb 26, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $42 → $50 | $37.83 | +32.17% | 4 | Feb 24, 2025 | |
| DOCS Doximity | Maintains: Hold | $60 → $71 | $58.51 | +21.35% | 9 | Feb 7, 2025 | |
| PINC Premier | Maintains: Hold | $21 → $19 | $19.14 | -0.73% | 12 | Feb 5, 2025 | |
| EVH Evolent Health | Maintains: Buy | $23 → $16 | $9.60 | +66.67% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $4.55 | +119.78% | 7 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.99 | - | 9 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $2.32 | +158.62% | 3 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $17 | $8.09 | +110.14% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $112.46 | +7.59% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.64 | +89.39% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.48 | +15,102.70% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $34.73 | -30.90% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $68.21 | +39.28% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $35.02 | -49.31% | 4 | Dec 20, 2018 |
Phreesia
Mar 13, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $26.00
Upside: +34.62%
Clover Health Investments
Mar 3, 2025
Maintains: Buy
Price Target: $4.2 → $4.5
Current: $3.59
Upside: +25.35%
Privia Health Group
Feb 28, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $22.59
Upside: +32.80%
Progyny
Feb 28, 2025
Maintains: Hold
Price Target: $17 → $23
Current: $21.90
Upside: +5.02%
HealthStream
Feb 26, 2025
Maintains: Hold
Price Target: $29 → $30
Current: $32.03
Upside: -6.34%
AdaptHealth
Feb 26, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $10.64
Upside: +31.58%
Waystar Holding
Feb 24, 2025
Maintains: Buy
Price Target: $42 → $50
Current: $37.83
Upside: +32.17%
Doximity
Feb 7, 2025
Maintains: Hold
Price Target: $60 → $71
Current: $58.51
Upside: +21.35%
Premier
Feb 5, 2025
Maintains: Hold
Price Target: $21 → $19
Current: $19.14
Upside: -0.73%
Evolent Health
Jan 23, 2025
Maintains: Buy
Price Target: $23 → $16
Current: $9.60
Upside: +66.67%
Jan 21, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $4.55
Upside: +119.78%
Jan 8, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.99
Upside: -
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.32
Upside: +158.62%
Aug 1, 2024
Maintains: Buy
Price Target: $25 → $17
Current: $8.09
Upside: +110.14%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $112.46
Upside: +7.59%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $2.64
Upside: +89.39%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.48
Upside: +15,102.70%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $34.73
Upside: -30.90%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $68.21
Upside: +39.28%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $35.02
Upside: -49.31%